Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

OABIW - OmniAb Inc - Warrants (01/11/2027)


Previous close
0.3642
0   0%

Share volume: 590
Last Updated: Tue 27 Aug 2024 06:00:00 AM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$0.36
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
7.29%
1 Month
-12.74%
3 Months
-26.68%
6 Months
-64.81%
1 Year
-62.72%
2 Year
-20.02%
Key data
Stock price
$0.36
P/E Ratio 
-7.94
DAY RANGE
N/A - N/A
EPS 
-$0.62
52 WEEK RANGE
$0.31 - $1.39
52 WEEK CHANGE
-$0.63
MARKET CAP 
495.102 M
YIELD 
N/A
SHARES OUTSTANDING 
5.750 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$4,837
AVERAGE 30 VOLUME 
$7,033
Company detail
CEO:
Region: US
Website:
Employees: 59
IPO year: -
Issue type:
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

the omniab discovery platform provides pharmaceutical industry partners access to diverse antibody repertoires and high-throughput screening technologies to enable discovery of next-generation therapeutics.

Recent news